(S (NP (NP (VBN Automated) (NN breast) (NN ultrasound)) (PRN (-LRB- -LRB-) (NP (NNP ABUS)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (ADJP (JJ new) (CC and) (JJ promising)) (NN imaging) (NN modality)) (PP (IN for) (NP (NN breast) (NN cancer) (NN detection) (CC and) (NN diagnosis))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD could) (VP (VB provide) (NP (NP (JJ intuitive) (CD 3D) (NN information)) (CC and) (NP (JJ coronal) (NN plane) (NN information))) (PP (IN with) (NP (JJ great) (JJ diagnostic) (NN value))))))))) (. .))
(S (ADVP (RB However)) (, ,) (S (S (VP (ADVP (RB manually)) (VBG screening) (CC and) (VBG diagnosing) (NP (NNS tumors)) (PP (IN from) (NP (NNP ABUS) (NNS images))))) (VP (VBZ is) (ADJP (RB very) (JJ time-consuming)))) (CC and) (S (NP (NP (NNS overlooks)) (PP (IN of) (NP (NNS abnormalities)))) (VP (MD may) (VP (VB happen)))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (JJ novel) (NN two-stage) (CD 3D) (NN detection) (NN network)) (PP (IN for) (S (VP (VP (VBG locating) (NP (VBN suspected) (NN lesion) (NNS areas))) (CC and) (VP (ADVP (JJ further)) (NN classifying) (NP (NNS lesions)) (PP (IN as) (NP (ADJP (NN benign) (CC or) (JJ malignant)) (NNS tumors))))))))) (. .))
(S (ADVP (RB Specifically)) (, ,) (S (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (CD 3D) (NN detection) (NN network)) (PP (RB rather) (IN than) (NP (JJ frequently-used) (NN segmentation) (NN network)))) (S (VP (TO to) (VP (VB locate) (NP (NNS lesions)) (PP (IN in) (NP (NNP ABUS) (NNS images)))))))) (, ,) (S (ADVP (RB thus)) (NP (PRP$ our) (NN network)) (VP (MD can) (VP (VB make) (NP (NP (JJ full) (NN use)) (PP (IN of) (NP (NP (DT the) (JJ spatial) (NN context) (NN information)) (PP (IN in) (NP (NNP ABUS) (NNS images))))))))) (. .))
(S (NP (DT A) (JJ novel) (NN similarity) (NN loss)) (VP (VBZ is) (VP (VBN designed) (S (VP (TO to) (VP (ADVP (RB effectively)) (JJ distinguish) (NP (NNS lesions)) (PP (IN from) (NP (NN background)))))))) (. .))
(S (RB Then) (NP (DT a) (NN classification) (NN network)) (VP (VBZ is) (VP (VBN employed) (S (VP (TO to) (VP (VB identify) (NP (DT the) (JJ located) (NNS lesions)) (PP (IN as) (ADJP (NN benign) (CC or) (NN malignant)))))))) (. .))
(S (NP (DT An) (JJ IoU-balanced) (NN classification) (NN loss)) (VP (VBZ is) (VP (VBN adopted) (S (VP (TO to) (VP (VB improve) (NP (NP (DT the) (NN correlation)) (PP (IN between) (NP (NN classification) (CC and) (NN localization) (NN task))))))))) (. .))
(S (NP (NP (DT The) (NN efficacy)) (PP (IN of) (NP (PRP$ our) (NN network)))) (VP (VBZ is) (VP (VBN verified) (PP (IN from) (NP (NP (DT a) (JJ collected) (NN dataset)) (PP (IN of) (NP (NP (CD 418) (NNS patients)) (PP (IN with) (NP (NP (CD 145) (JJ benign) (NNS tumors)) (CC and) (NP (CD 273) (JJ malignant) (NNS tumors)))))))))) (. .))
(S (NP (NNS Experiments)) (VP (VBP show) (SBAR (S (NP (PRP$ our) (NN network)) (VP (VP (VBZ attains) (NP (NP (DT a) (NN sensitivity)) (PP (IN of) (NP (CD 97.66) (NN %)))) (PP (IN with) (NP (NP (CD 1.23) (JJ false) (NNS positives)) (PRN (-LRB- -LRB-) (NP (NNP FPs)) (-RRB- -RRB-))))) (, ,) (CC and) (VP (VBZ has) (NP (NP (DT an) (NN area) (PP (IN under) (NP (DT the) (NN curve))) (PRN (-LRB- -LRB-) (NP (NNP AUC)) (-RRB- -RRB-)) (NN value)) (PP (IN of) (NP (CD 0.8720))))))))) (. .))
